Assessment of impact of structured education regarding COVID – 19 among higher secondary school children among selected schools of Kalaburagi City

  • Anu Theresa Jose Department of Pharmacy Practice, Rajiv Memorial Education Society’s College of Pharmacy, Kalaburagi -585102, Karnataka
  • A V Kishore Babu Department of Pharmacy Practice, Rajiv Memorial Education Society’s College of Pharmacy, Kalaburagi -585102, Karnataka
  • Anith Rajeev Department of Pharmacy Practice, Rajiv Memorial Education Society’s College of Pharmacy, Kalaburagi -585102, Karnataka
  • Amal Raj BS Department of Pharmacy Practice, Rajiv Memorial Education Society’s College of Pharmacy, Kalaburagi -585102, Karnataka
  • Vinod Immanuel Department of Pharmacy Practice, Rajiv Memorial Education Society’s College of Pharmacy, Kalaburagi -585102, Karnataka

Abstract

Background: The Coronavirus disease-2019 (COVID-19) is considered as an emerging respiratory disease that is highly infectious, and was detected in December 2019 in Wuhan, China. According to WHO, Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases. Understanding people’s perceptions of disease will provide tools to improve strategies to limit its transmission. This study aims to assess the knowledge, attitude and practices (KAP) associated with the disease among higher secondary school students. Objectives: The primary objective was to assess the knowledge, attitude and practices regarding COVID-19. The secondary objective was to improve and compare the knowledge, attitude and practices regarding COVID-19 among the school children. Materials and Methods: A community based prospective educational study was conducted among higher secondary school children of randomly selected schools in Kalaburagi city. All the selected students in the study were provided with a data collection form and assent form including self-structured questionnaires. After pre-test all the students were educated regarding COVID-19 by means of PowerPoint presentations, videos and information- leaflets on COVID-19. Post-test has been conducted after a gap of 14 days of education by means of same questionnaires. Data were collected and entered into excel and results were analyzed. Pre-test and post-test intervention data were compared using student t- test. Result: A statistically significant difference between secondary school students’ knowledge, attitudes, and practices before and after educational intervention. In the post-test, all 220 students had a good knowledge (95.7%), attitude (94.2%), and practice (92.5%) level with a very highly statistical significance which improved after structured education. Conclusion: The findings have revealed that secondary school students' knowledge, attitude, and practice have been improved after the structured education by clinical pharmacist.

Keywords: SARS-CoV-2, International Committee on Taxonomy of Viruses, Wuhan- China, COVID-19, Vaccine, Pandemic

Downloads

Download data is not yet available.

References

1. https://www.who.int/westernpacific/healthtopics/detail/coronavirus#:~:text=Coronaviruses %20(CoV)%20are%20a%20large,been%20previously%20identified%20in%20humans
2. Subedi D, Bhandari S, Gaire A. Knowledge, Attitude, and Practices Associated with COVID- 19 Among School Students in Bharatpur, Chitwan District Nepal.IJMS 2020;8(3):231-237.
3. Kasemy A Z, Bahbah W A, Zewain S K. Knowledge, Attitude and Practice toward COVID- 19 among Egyptians’ JEGH 2020;10(4):378-385.
4. Taneja D, Khurana A. An Online cross-sectional survey on knowledge, attitudes, practices and perspectives of homeopathic practitioners towards COVID-19. IJRH 2020;14(2):145-194.
5. Koyama T, Platt D, Parida L. Variant analysis of SARS-CoV-2 genomes. BWHO 2020; 98:495-504.
6. Paul A, Sikdar S, Hossain M M. Knowledge, attitudes, and practices toward the novel coronaviruses among Bangladeshis: Implications for mitigations measures. IJP 2020;1-18.
7. Image drawn from CDC news room.
8. Gahlot A, Singh S P, Verma V. A Study Of knowledge, attitude and practices regarding SARS COV-2 infection and its control amongst medical students of Rama Medical College Kanpur.IJFCM 2020;7(3):134-139.
9. Asraf H, Garima T, Singh B M. Knowledge, attitudes, and practices towards COVID -19 among Nepalese Residents: A quick online cross-sectional survey. AJMS 2020;11(3).
10. Image drawn from WHO, CDC.
11. Image drawn from TIME Magazine front cover May 10/May 17 2021 double issue.
12. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19--- 29-june-2021.
13. https://covid19.karnataka.gov.in/english
14. https://kalaburagi.nic.in/en/covid-19-eng/
15. Watsala, Awasthi A, Taneja N, Janardhanan R. Knowledge Attitude and Practice towards COVID-19 Pandemic among residents of Bihar, India. IJRSR 2020;11(06):38990-38995.
16. Teferi S C.A Review on Knowledge, Attitude, Practice during the COVID -19 Pandemic in Ethiopia. IJVID 2020;5(2):040-044.
17. Khodor S, Kumar M. Pathophysiology and treatment strategies for COVID-19. J transl Med;(2020) 18:353.
18. Image drawn from Frontiers.https://apps.who.int/iris/handle/10665/331329.2021.
19. Image drawn from knowable magazine.
20. Fehr R A, Perlman S. Coronaviruses: An Overview of Their Replication and Pathogenesis. Helena Jane Maier et al. (eds.), Coronaviruses: Methods and Protocols, Methods in Molecular Biology,2015 ;1282: 978-4939.
21. Licastro D, Rajashekharan S. Isolation and Full-Length Genome Characterization of SARSCoV-2 from COVID-19 Cases in Northern Italy. Jvi 2020; 94 (11) e00543-20.
22. Wu A, Peng Y. Genome Composition and Divergence of the Novel Coronavirus (2019- nCoV) Originating in China.CHM 2020;325-328.
23. Hoffman M, Weber H K, Shroeder S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. CP 2020; 181:271-280. 25.Jaimes J A, Millet J K, Whittaker G R. Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site. iScience 2020; 23:101212.
24. Image drawn from Journal of translational medicine.
25. Schoeman D, Fielding B C. Coronavirus envelope protein: current knowledge. VJ 2019; 16(69) 1-22.
26. OVID -19 Antiviral and pharmacotherapy information Nebraska medicine /4/12/2021.
27. Smith T, BCPS; Bushek J; PharmD. COVID -19 Drug therapy. CDI/CS 2020.
28. Sanayolu A, Okorie C, Marinkovic A. Comorbidity and its Impact on Patients with COVID- 19.SN 2020; https://doi.org/10.1007/s42399-020-00363-4.
29. Guan W-j, Liang W-h, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55: 2000547 [https://doi.org/10.1183/13993003.00547-2020].
30. Abhilasha, Mitra P. Association of Comorbidities with Coronavirus Disease 2019: A Review. Ann Natl Acad Med Sci (India):2020; 2:102–111.
31. CDC. National Diabetes Statistics Report | Data & Statistics | Diabetes | CDC. Available at: https://www.cdc.gov/diabetes/ data/statistics/statistics-report.html. Accessed May 17, 2020.
32. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020. Doi: 10.1001/jama.2020.4683
33. Ferguson N, Laydon D, Nedjati Gilani G, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Available at: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida- fellowships/Imperial-College-COVID19NPI-modelling-16-03-2020.pdf. Accessed June 22, 2020.
34. CDC COVID-19 Response Team. Severe outcomes among patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. Morb Mortal Wkly Rep 2020;69(12):343–346.
35. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41(2):145–151.
36. Kreutz R, Algharably EA, Azizi M, et al. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res 2020. Doi:10.1093/cvr/cvaa097.
37. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420–422.
38. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020. 191:145–147.
39. Arleevskaya MI, Shafigullina AZ, Filina YV, Lemerle J, Renaudineau Y. Associations between viral infection history symptoms, granulocyte reactive oxygen species activity, and active rheumatoid arthritis disease in untreated women at onset: results from a longitudinal cohort study of Tatarstan women. Front Immunol 2017; 8:1725.
40. Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 2013;52(1):53–61.
41. Galloway JB, Hyrich KL, Mercer LK, et al; BSRBR Control Centre Consortium; British Society for Rheumatology Biologics Register. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 2011;50(1):124–131.
42. Bernal J P, Andrews N, Gower C et al. Effectiveness of COVID-19 vaccines against
43. B.1.617.2 (Delta) Variant. N ENGL J MED 2021;1-10.
44. Image drawn from www.immunology.org.
45. https://www.webmd.com/vacines/covid-19-vaccine/default.htm.
46. Pathak H. India’s COVID-19 Vaccination Campaign: A Marathon, Not a Sprint/ORF Special report no.143/June 2021.
47. Galvin C J, Li U C (Jack), Malwade S. COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan. IJID 98 2020; 18-20.
48. Image drawn from Tiger encounter.com.
49. Souli D, Dilucca M. Knowledge, attitude and practice of secondary school students toward COVDI-19 epidemic in Italy: a cross sectional study.
50. Padamanaban S, Rajendran P, Davis P et al. Knowledge, attitude and practices towards COVID-19 among higher education students in India: a cross sectional study.JPB 2021.
51. Ayed M M A, Mohamed A E, Mahmoud TM et al., Impact of Educational Intervention on Secondary School Students’ Knowledge, Practices and Attitudes Regarding to COVID- 19.2020.
52. Tadesse A W, Melese N et al., Knowledge, attitude and practice and associated factors towards COVID-19 among college students in Ambara region, Ethiopia; A cross sectional study.
53. Maheshwari S, Gupta P K, Sinha R et al., Knowledge, attitude, and practice towards Coronavirus disease 2019 (COVID-19) among medical students: A cross-sectional study.JAD 2020;9(3):100-104.
54. Thenmozhi, Bhuvaneshwari. Knowledge, Attitude and Practices towards COVID-19 among Undergraduate Students: Web-Based Cross-Sectional Study.SJNHC 2021;4(7):164-169.
Published
06/04/2023
Statistics
123 Views | 51 Downloads
Citatons
How to Cite
Jose, A. T., A, V. K. B., Rajeev, A., S, A. R. B., & Immanuel , V. (2023). Assessment of impact of structured education regarding COVID – 19 among higher secondary school children among selected schools of Kalaburagi City. Journal of Innovations in Applied Pharmaceutical Science (JIAPS), 8(1), 20-31. https://doi.org/10.37022/jiaps.v8i1.431
Section
Research Article(S)